AbstractSome patients who need dual antiplatelet
therapy sometimes require tracheotomy. Aim of this study
was to compare the rate of complications during and
after surgical tracheotomy between patients requiring
dual antiplatelet therapy and those without dual antiplatelet
therapy. We retrospectively included 79 patients
(62% men, mean age 64 ± 14 years) in the period 2007-
2011. The following complications were analyzed: need
for surgical revision within 24 hours after tracheotomy,
need for bronchoscopy within 24 hour after tracheotomy,
need for blood transfusion within 24 hours after tracheotomy,
death attributed to tracheotomy and any complication
attributed to tracheotomy. We compared patients
where tracheotomy was performed while receiving dual
antiplatelet therapy (n=27, 34%) to patients where tracheotomy
was performed without dual antiplatelet therapy
(n=52, 66%). Nonsignificant differences between the two
groups were observed general characteristics. There were
no statistically significant differences in complications
after tracheotomy (surgical revision after tracheotomy
p=0.63, bronchoscopy after tracheotomy p=0.74, blood
transfusion after tracheotomy p=0.59, death attributed to
tracheotomy p=1.00 and any complication attributed to
tracheotomy p=1.00). The study shows that tracheotomy
is safe in cardiac patients on dual antiplatelet therapy.
Effect of platelet-rich fibrin versus chitosan-based Axiostat hemostatic agent following dental extraction in cardiac patients on antiplatelet therapy: A comparative study
